Cargando…
3D Tumor Models and Their Use for the Testing of Immunotherapies
Over the past decade, immunotherapy has become a powerful and evident tool in the fight against cancers. Notably, the rise of checkpoint blockade using monoclonal antibodies (anti-CTLA4, anti-PD1) to avoid interaction between inhibitory molecules allowed the betterment of patient care. Indeed, immun...
Autores principales: | Boucherit, Nicolas, Gorvel, Laurent, Olive, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7758240/ https://www.ncbi.nlm.nih.gov/pubmed/33362787 http://dx.doi.org/10.3389/fimmu.2020.603640 |
Ejemplares similares
-
Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
por: Degos, Clara, et al.
Publicado: (2019) -
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
por: Demerlé, Clemence, et al.
Publicado: (2021) -
Editorial: Recent 3D Tumor Models for Testing Immune-Mediated Therapies
por: Zimmer, Jacques, et al.
Publicado: (2021) -
Characterizing the Role of Monocytes in T Cell Cancer Immunotherapy Using a 3D Microfluidic Model
por: Lee, Sharon Wei Ling, et al.
Publicado: (2018) -
Targeting the “PVR–TIGIT axis” with immune checkpoint therapies
por: Gorvel, Laurent, et al.
Publicado: (2020)